Your browser doesn't support javascript.
loading
Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.
Saini, Sarbjit S; Omachi, Theodore A; Trzaskoma, Benjamin; Hulter, Henry N; Rosén, Karin; Sterba, Patricia M; Courneya, Jean-Paul; Lackey, Alan; Chen, Hubert.
Affiliation
  • Saini SS; Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
  • Omachi TA; Genentech, Inc., South San Francisco, California, USA.
  • Trzaskoma B; Genentech, Inc., South San Francisco, California, USA.
  • Hulter HN; Genentech, Inc., South San Francisco, California, USA.
  • Rosén K; Genentech, Inc., South San Francisco, California, USA.
  • Sterba PM; Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
  • Courneya JP; Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
  • Lackey A; LabCorp Clinical Trials, Brentwood, Tennessee, USA.
  • Chen H; Genentech, Inc., South San Francisco, California, USA. Electronic address: chenh37@gene.com.
J Invest Dermatol ; 137(4): 958-961, 2017 04.
Article in En | MEDLINE | ID: mdl-27939380

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Basophils / Anti-Allergic Agents / Omalizumab Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Basophils / Anti-Allergic Agents / Omalizumab Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2017 Document type: Article Affiliation country: